Cargando…
The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors
Upregulation of phosphoglycerate mutase 1 (PGAM1) has been identified as one common phenomenon in a variety of cancers. Inhibition of PGAM1 provides a new promising therapeutic strategy for cancer treatment. Herein, based on our previous work, a series of new N-xanthone benzenesulfonamides were disc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100356/ https://www.ncbi.nlm.nih.gov/pubmed/29890679 http://dx.doi.org/10.3390/molecules23061396 |
_version_ | 1783348854474670080 |
---|---|
author | Wang, Penghui Jiang, Lulu Cao, Yang Ye, Deyong Zhou, Lu |
author_facet | Wang, Penghui Jiang, Lulu Cao, Yang Ye, Deyong Zhou, Lu |
author_sort | Wang, Penghui |
collection | PubMed |
description | Upregulation of phosphoglycerate mutase 1 (PGAM1) has been identified as one common phenomenon in a variety of cancers. Inhibition of PGAM1 provides a new promising therapeutic strategy for cancer treatment. Herein, based on our previous work, a series of new N-xanthone benzenesulfonamides were discovered as novel PGAM1 inhibitors. The representative molecule 15h, with an IC(50) of 2.1 μM, showed an enhanced PGAM1 inhibitory activity and higher enzyme inhibitory specificity compared to PGMI-004A, as well as a slightly improved antiproliferative activity. |
format | Online Article Text |
id | pubmed-6100356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61003562018-11-13 The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors Wang, Penghui Jiang, Lulu Cao, Yang Ye, Deyong Zhou, Lu Molecules Communication Upregulation of phosphoglycerate mutase 1 (PGAM1) has been identified as one common phenomenon in a variety of cancers. Inhibition of PGAM1 provides a new promising therapeutic strategy for cancer treatment. Herein, based on our previous work, a series of new N-xanthone benzenesulfonamides were discovered as novel PGAM1 inhibitors. The representative molecule 15h, with an IC(50) of 2.1 μM, showed an enhanced PGAM1 inhibitory activity and higher enzyme inhibitory specificity compared to PGMI-004A, as well as a slightly improved antiproliferative activity. MDPI 2018-06-08 /pmc/articles/PMC6100356/ /pubmed/29890679 http://dx.doi.org/10.3390/molecules23061396 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Wang, Penghui Jiang, Lulu Cao, Yang Ye, Deyong Zhou, Lu The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title | The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title_full | The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title_fullStr | The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title_full_unstemmed | The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title_short | The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors |
title_sort | design and synthesis of n-xanthone benzenesulfonamides as novel phosphoglycerate mutase 1 (pgam1) inhibitors |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100356/ https://www.ncbi.nlm.nih.gov/pubmed/29890679 http://dx.doi.org/10.3390/molecules23061396 |
work_keys_str_mv | AT wangpenghui thedesignandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT jianglulu thedesignandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT caoyang thedesignandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT yedeyong thedesignandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT zhoulu thedesignandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT wangpenghui designandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT jianglulu designandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT caoyang designandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT yedeyong designandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors AT zhoulu designandsynthesisofnxanthonebenzenesulfonamidesasnovelphosphoglyceratemutase1pgam1inhibitors |